JP2025522146A - 不眠症を治療するための医薬組成物および方法 - Google Patents

不眠症を治療するための医薬組成物および方法 Download PDF

Info

Publication number
JP2025522146A
JP2025522146A JP2025524504A JP2025524504A JP2025522146A JP 2025522146 A JP2025522146 A JP 2025522146A JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025522146 A JP2025522146 A JP 2025522146A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
alprazolam
ebastine
present
amount ranging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025524504A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025522146A5 (enExample
Inventor
ワン，ジアンミン
ツイ，ゴーピン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2025522146A publication Critical patent/JP2025522146A/ja
Publication of JP2025522146A5 publication Critical patent/JP2025522146A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4515—Non condensed piperidines, e.g. piperocaine having a butyrophenone group in position 1, e.g. haloperidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2025524504A 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法 Pending JP2025522146A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2022/036579 WO2024010592A1 (en) 2022-07-08 2022-07-08 Pharmaceutical compositions and methods for treating insomnia

Publications (2)

Publication Number Publication Date
JP2025522146A true JP2025522146A (ja) 2025-07-10
JP2025522146A5 JP2025522146A5 (enExample) 2025-07-17

Family

ID=89453886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025524504A Pending JP2025522146A (ja) 2022-07-08 2022-07-08 不眠症を治療するための医薬組成物および方法

Country Status (7)

Country Link
US (1) US20250205218A1 (enExample)
EP (1) EP4551220A4 (enExample)
JP (1) JP2025522146A (enExample)
CN (1) CN119255803A (enExample)
AU (1) AU2022468585A1 (enExample)
CA (1) CA3261198A1 (enExample)
WO (1) WO2024010592A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12370198B2 (en) 2022-07-08 2025-07-29 La Pharmatech Inc Pharmaceutical compositions and methods for treating psychiatric disorders

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005179311A (ja) * 2003-12-24 2005-07-07 Lion Corp ゼリー状睡眠薬製剤
JP2007524652A (ja) * 2003-09-26 2007-08-30 アルザ・コーポレーシヨン アルプラゾラムの制御送達のための浸透性投薬形態物
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
JP2010534705A (ja) * 2007-07-27 2010-11-11 グラクソ グループ リミテッド Ｈ１受容体のアンタゴニストとして有用なスピロ化合物
JP2016536371A (ja) * 2014-02-06 2016-11-24 シーケンシャル メディシン リミテッド 睡眠を補助する組成物及び方法
JP2021522299A (ja) * 2018-05-02 2021-08-30 フェリング・ベー・フェー 改良製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2403193T3 (es) * 2008-02-05 2013-05-16 Laboratorios Bago S.A. Composiciones que comprenden alprazolam para el tratamiento del insomnio primario y del insomnio asociado con estados de ansiedad y procedimientos para su preparación
US10898493B2 (en) * 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
EP3996697A1 (fr) * 2019-07-09 2022-05-18 Université de Bretagne Occidentale (U.B.O.) Nouveaux composés inhibiteurs de la pfar

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007524652A (ja) * 2003-09-26 2007-08-30 アルザ・コーポレーシヨン アルプラゾラムの制御送達のための浸透性投薬形態物
JP2005179311A (ja) * 2003-12-24 2005-07-07 Lion Corp ゼリー状睡眠薬製剤
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
JP2010534705A (ja) * 2007-07-27 2010-11-11 グラクソ グループ リミテッド Ｈ１受容体のアンタゴニストとして有用なスピロ化合物
JP2016536371A (ja) * 2014-02-06 2016-11-24 シーケンシャル メディシン リミテッド 睡眠を補助する組成物及び方法
JP2021522299A (ja) * 2018-05-02 2021-08-30 フェリング・ベー・フェー 改良製剤

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
"１９０９ＰＩ−３Ｃ エバスチンＯＤ錠５ｍｇ「ＮＰ」／エバスチンＯＤ錠１０ｍｇ「ＮＰ」", 医薬品インタビューフォーム, vol. 第３版, JPN6026030364, 2019, ISSN: 0005913715 *
"レスタミンコーワ錠１０ｍｇ", 医薬品インタビューフォーム, vol. 第6版, JPN6026030363, 2000, ISSN: 0005913714 *
CLINICAL AND EXPERIMENTAL ALLERGY, vol. Vol. 29, Supp. 3, JPN6026030360, 1999, pages 133 - 142, ISSN: 0005913712 *
CURRENT MEDICAL RESEARCH AND OPINION, vol. 17, no. 4, JPN6026030362, 2008, pages 273 - 281, ISSN: 0005913717 *
PLOS ONE, vol. Vol. 9, No. 12, e114336, JPN6026030361, 2014, pages 1 - 17, ISSN: 0005913713 *
日本薬局方エバスチン口腔内崩壊錠（添付文書）, JPN6026030359, 2019, ISSN: 0005913711 *
薬学雑誌, vol. 141, no. 1, JPN6026030365, 2021, pages 93 - 110, ISSN: 0005913716 *

Also Published As

Publication number Publication date
EP4551220A1 (en) 2025-05-14
EP4551220A4 (en) 2026-05-06
WO2024010592A1 (en) 2024-01-11
AU2022468585A1 (en) 2025-02-20
US20250205218A1 (en) 2025-06-26
CN119255803A (zh) 2025-01-03
CA3261198A1 (en) 2024-01-11

Similar Documents

Publication Publication Date Title
KR101801864B1 (ko) 인플루엔자, 감기 및 염증의 치료에서 레보세티리진 및 몬테루카스트의 용도
US10898493B2 (en) Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
CN113924098A (zh) 治疗精神障碍、行为障碍、认知障碍的方法
US20200101067A1 (en) Use of levocetirizine and montelukast in the treatment of anaphylaxis
TW202339764A (zh) 19去甲c3,3-二取代之c21-n-吡唑類固醇及其使用方法
US20210069209A1 (en) Novel pharmaceutical compositions and methods for menopause related anxiety and depression
US20230285408A1 (en) Method of treating dementia
KR20150135339A (ko) 레보세티리진 및 몬테루카스트의 외상성 손상의 치료 용도
WO2021242297A1 (en) Novel pharmaceutical compositions and methods for menopause related anxiety and depression
US20250205218A1 (en) Pharmaceutical compositions and methods for treating insomnia
US11744833B2 (en) Pharmaceutical compositions and methods for treatment of insomnia
JP2025526852A (ja) 不眠症の治療のための新規医薬組成物及び方法
JP2025518975A (ja) 精神疾患の治療のための新規医薬組成物及び方法
CN1327843C (zh) 氟马西尼在用于可卡因依赖治疗药物制备中的应用
US11628174B1 (en) Pharmaceutical compositions and methods for treating insomnia
CN1268332C (zh) 用于治疗膀胱疾病的k－阿片受体激动剂
US10071077B2 (en) Use of enoximone in the treatment of atopic immune-related disorders, in pharmaceutical composition as well as in pharmaceutical preparation
US12370198B2 (en) Pharmaceutical compositions and methods for treating psychiatric disorders
HK40119515A (en) Novel pharmaceutical compositions and methods for treatment of insomnia
CN102470125A (zh) 苄达明在治疗p40-依赖性疾病中的用途
JPWO2005063253A1 (ja) アレルギー症状治療用医薬組成物
WO2026080932A2 (en) Compounds, compositions, and methods of use thereof
Yildiz Non-Allergic Rhinitis
CN115364085A (zh) 一种用于缓解早泄的组合片
HK1064036B (en) Kapp-opiate agonists for the treatment of bladder dieseases

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250708

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260715

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260721